Crotty, Shane P
- La Jolla Institute for Immunology (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,323
- Sustained Excellence
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$3.6M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,323
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Crotty, Shane P as a PI. Multi-PI records show the full award amount for context.
- 5U19AI142742-05U19Contact PIFunctional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses$2.7Maward amount
- 5R37AI125068-08R37Contact PIMaximizing germinal centers and somatic hypermutation to HIV Env immunogens$869.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Crotty, Shane P as a PI.
FY2023 award administered by La Jolla Institute for Immunology (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardLa Jolla Institute for Immunology
- 2007$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2008$2M Cumulative Funding
- 2008Entered Top 50% NationallyRanked #1149
- 2008Entered Top 25% NationallyRanked #1149
- 2008Entered Top 10% NationallyRanked #1149
- 2009$5M Cumulative Funding
- 2011$10M Cumulative Funding
- 2016Entered Top 5% NationallyRanked #908
- 2017$25M Cumulative Funding
- 2021$50M Cumulative Funding